You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Benserazide, levodopa drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Parkinson Disease Trial in Seoul (Levodopa dispersible, Levodopa)

Completed
  • Parkinson Disease
  • Seoul, Korea, Republic of
  • +1 more
May 4, 2021

Healthy Trial (single-dose madopar, single-dose propranolol, and single-dose by order, single-dose madopar, single-dose , and

Not yet recruiting
  • Healthy
  • single-dose madopar, single-dose propranolol, and single-dose placebo by order
  • +5 more
  • (no location specified)
Sep 13, 2023

Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)

Recruiting
  • Parkinson Disease
  • Memory Impairment
  • Madopar monotherapy
  • +2 more
  • Beijing, China
    Peking University Third Hospital
Jul 8, 2021

Parkinson, Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in Sofia (Levodopa Cyclops™, INBRIJA®)

Not yet recruiting
  • Parkinson
  • +2 more
  • Levodopa Cyclops™
  • INBRIJA®
  • Sofia, Bulgaria
    Bed space for short term stay at Diagnostic & Consultative Centr
Sep 13, 2023

Parkinson Disease Trial in Anyang-si (Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg)

Recruiting
  • Parkinson Disease
  • Ongentys 50mg
  • Madopar Tab. 125 or Perkin Tab. 25-100mg
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Hallym University Sacred Heart Hospital
Jun 17, 2021

Parkinson Disease Trial (Opicapone, L-DOPA/DDCI)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Oct 13, 2021

Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)

Completed
  • Parkinson Disease
  • Standard LD/CD
  • Semi continuous intra-oral administration of LD/CD
  • Rome, Italy
    Irccs San Raffaele Pisana
Oct 17, 2022

Stroke Trial in Charlestown (Placebo, Levodopa / Carbidopa, Armeo)

Withdrawn
  • Stroke
  • Placebo
  • +2 more
  • Charlestown, Massachusetts
    Spaulding Rehabilitation Hospital
Dec 17, 2021

Diabetic Retinopathy Trial in Decatur (Sinemet CR, )

Enrolling by invitation
  • Diabetic Retinopathy
  • Sinemet CR
  • placebo
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jul 14, 2022

Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)

Recruiting
  • Parkinson Disease
  • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
  • Ahmedabad, Gujarat, India
    Lambda Therapeutic Research Ltd.
Nov 10, 2021

Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

Not yet recruiting
  • Idiopathic Parkinson Disease
  • levodopa/carbidopa oral formulation A
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
Jul 20, 2022

Depression Trial in Atlanta (Levodopa+carbidopa, Placebo)

Completed
Has Results
  • Depression
  • Atlanta, Georgia
    Emory University Hospital
Aug 24, 2022

Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)

Suspended
  • Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022

Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)

Completed
Has Results
  • Advanced Parkinson's Disease
  • Little Rock, Arkansas
  • +10 more
May 11, 2022

Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)

Recruiting
  • Parkinson Disease
  • WD-1603 Carbidopa-Levodopa Extended-Release Tablets
  • Placebo
  • Shanghai, Shanghai, China
    Shanghai Huashan Hospital
Oct 28, 2021

Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)

Active, not recruiting
  • Parkinson's Disease
  • Continuous intrajejunal infusion of levodopa-carbidopa
  • deep brain stimulation
  • Amsterdam, Noord Holland, Netherlands
    Academic Medical Center
Apr 20, 2022

Acute Pain, Bunionectomy, Toe Fusion Trial in Chicago (Carbidopa-Levodopa (100mg/25mg):, Naproxen)

Recruiting
  • Acute Pain
  • +2 more
  • Chicago, Illinois
  • +1 more
Nov 16, 2021

Advanced Parkinson's Disease Trial in Worldwide (Levodopa-carbidopa intestinal gel, CADD-Legacy® 1400 ambulatory infusion pump)

Completed
  • Advanced Parkinson's Disease
  • Levodopa-carbidopa intestinal gel
  • CADD-Legacy® 1400 ambulatory infusion pump
  • Birmingham, Alabama
  • +60 more
Nov 3, 2021

Parkinson's Disease, Obstructive Sleep Apnea Trial in Montreal (Sinemet CR, Placebo oral capsule)

Recruiting
  • Parkinson's Disease
  • Obstructive Sleep Apnea
  • Sinemet CR
  • Placebo oral capsule
  • Montreal, Quebec, Canada
    McGill University Health Centre
Aug 28, 2021

Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

Recruiting
  • Idiopathic Parkinson's Disease
  • PD patients H&Y=1.5-2 Medications ON
  • +4 more
  • Pozzilli, Isernia, Italy
    IRCSS Neuromed Hospital
May 18, 2022

Reduction of Levodopa and Non-motor Symptoms of Parkinson's

Completed
  • Parkinson Disease
  • Visual Impairment
  • Jinan, Sichuan, China
    Chao Zhang
Jun 4, 2023

Parkinson's Disease, Dyskinesias, Movement Disorders Trial in Portland (Buspirone, Placebo)

Terminated
  • Parkinson's Disease
  • +2 more
  • Portland, Oregon
    VA Portland Health Care System
Mar 3, 2021

Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)

Recruiting
  • Chronic Pain
  • Rochester, New York
    University of Rochester Medical Center
Jan 9, 2023

MDD, Dysthymia, Depression Trial in New York (L-DOPA, Placebo Oral Tablet)

Suspended
  • Major Depressive Disorder
  • +2 more
  • New York, New York
    New York State Psychiatric Institute
Jan 26, 2022